The Cancer Genome Atlas was launched in 2006 as a joint endeavor between the National Cancer Institute (NCI) and the National Human Genome Research Institute. The program was created to bring together multidisciplinary teams of researchers from across many institutions with the goal of improving understanding of cancer by cataloging genetic alterations found in tumor samples.
According to the NCI, TCGA has characterized more than 20,000 primary cancers and matched normal samples from more than 11,000 patients across 33 different cancer types. The effort has united 20 collaborating institutions from the U.S. and Canada, and the data remains freely available the public.
“TCGA has proven itself an invaluable resource for researchers, leading to significant advances in cancer prevention, diagnosis and treatment,” says Peter WT Pisters, M.D., president. “This incredible effort represents the pinnacle of team science, which is key to meaningful scientific progress. Collaborative research is at the core of our approach at MD Anderson, and we are proud to honor those who have contributed to this success.”
The AACR Team Science Award was established by AACR and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and translating research discoveries into clinical applications.